D. Montani (Verrieres Le Buisson, France), H. Olschewski (Graz, Austria)
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
S. Pizarro, V. I. Peinado, M. Vives, M. Diez, E. Ferrer, L. Molins, Y. Torralba, R. Rodríguez-Roisin, J. Roca, J. A. Barberà (Barcelona, Spain)
|  |
Pulmonary arteriovenous malformation (PAVM) in Japan
J. Omura, M. Sakuma, O. Yamada, H. Morisaki, N. Nakanishi (Osaka, Japan)
| |
Safety of long-term sildenafil 20 or 80 mg TID in patients with pulmonary arterial hypertension (PAH)
M. Kurzyna, W. Jachec, A. Jurgilewicz, L. J. Hwang (Warsaw, Zabrze, Poland; Paris, France; New York, United States Of America)
| |
Endothelin receptor antagonist (ETRA) bosentan (B) in patients with severe pulmonary hypertension (PH) associated with pulmonary disease
A. Stanziola, M. D‘Alto, E. Carpentieri, P. Argiento, C. Russo, E. Romeo, A. Molino, R. Calabrò, M. Sofia (Naples, Italy)
| |
Long–term follow-up of patients on sildenafil from Croatian pulmonary hypertension registry
M. Jakopovic, M. Samarzija, E. Zuljevic, Z. Dumija, G. Redzepi, A. Koprivanac, Z. Franic (Zagreb, Croatia)
|  |
Endothelial dysfunction in patients with occupational lung diseases
A. Ipatov, S. Panina, O. Soya, L. Volkova, N. Sanina (Dnipropetrovs‘k, Ukraine)
| |
Association of Met235Thr polymorphism of AGT gene with high altitude pulmonary arterial hypertension in Kyrgyz highlanders
A. Aldashev, N. Sovhozova, J. Isakova, B. Kojonazarov (Bishkek, Kyrgyzstan)
| |
Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery
C. Cortes, P. Mateo, T. De Guia (Quezon City, Philippines)
| |
Biomarkers in pulmonary hypertension associated to interstitial lung disease
C. U. Andersen, S. Mellemkjær, J. E. Nielsen-Kudsk, U. Simonsen, O. Hilberg, E. Bendstrup (Århus, Denmark)
| |
Pulmonary artery aneurysms in Behçet disease
M. Mjid, M. Zarrouk, N. Chaouch, B. Hamdi, H. Racil, S. Cheikh Rouhou, O. Rekhis, K. Marniche, K. Marniche, K. Marniche, A. Chabbou (Ariana, Tunisia)
| |
Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies
J. Meireles, M. Santos, A. Reis (Porto, Portugal)
| |
Clinical sildenafil use in Belgian patients with pulmonary arterial hypertension (PAH)
M. Delcroix, R. Naeije, S. Huez, W. A. Wuyts, H. Campenhout, J. L. Vachiéry (Leuven, Brussels, Belgium)
| |
The national program of pulmonary hypertension in Romania, past, present and future
T. Constantinescu, D. C. Zaharia, M. S. Mitrache, C. Ginghina, I. M. Coman, T. Mihaescu, D. Tesloianu, V. Tudorache, N. Bertici, R. Capalneanu, M. A. Bogdan (Bucharest, Iasi, Timisoara, Cluj, Romania)
| |
Etiology of severe reduction of single-breath carbon monoxide diffusion coefficient. Study of 195 cases
L. Kiakouama, V. Cottin, J. C. Glerant, J. Y. Bayle, J. F. Cordier (France)
| |
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
J. K. Hennigs, H. J. Baumann, B. Schulte-Hubbert, M. Halank, H. Klose (Hamburg, Dresden, Germany)
| |
Impact of water immersion on capillary lung volume (Vc) in healthy subjects
L. Bertoletti, F. Chouchou, M. Guillot-Gautier, J. C. Barthelemy, F. Roche, F. Costes (Saint-Etienne, France)
| |
Ventilation–perfusion ratios assessed by electrical impedance tomography in experimental ALI
H. Truebel, E. M. Becker, G. Hahn, J. Dittmar, G. Hellige (Wuppertal, Göttingen, Germany)
| |
Prognostic value of cardiac and lung abnormalities in hepatic transplant recipients
I. Enache, S. Doutreleau, M. L. Woehl-Jaegle, P. DiMarco, A. Charloux, M. Oswald-Mammosser (Strasbourg, France)
| |
Investigating line infections in pulmonary hypertension; a comparison of microbial growth in 3 commercially available preparations
J. Perry, A. Nicolson, F. K. Gould, P. Corris, A. De Soyza (Newcastle upon Tyne, United Kingdom)
| |